发明名称 LAQUINIMOD FOR TREATMENT OF CANNABINOID RECEPTOR TYPE 1 (CB1) MEDIATED DISORDERS
摘要 This invention provides a method of treating a human subject suffering from a CB1 receptor related disorder comprising periodically administering to the subject an effective amount of laquinimod or pharmaceutically acceptable salt thereof in an amount effective to treat the subject.
申请公布号 EP2882495(A1) 申请公布日期 2015.06.17
申请号 EP20130829849 申请日期 2013.08.12
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD. 发明人 MARTINO, GIANVITO;CENTONZE, DIEGO
分类号 A61P25/02;A61K31/4704 主分类号 A61P25/02
代理机构 代理人
主权项
地址